Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NH › Greenfield › NPI 1235115213
NP / PA

Clark, Mark

Clark, Mark was paid $47K by Medicaid between Jun 2020 and Mar 2023, across 6 billing codes. Its largest line is S9083, Global fee urgent care centers — 47% of everything it billed.

33Billing provider infoCLARK, MARK
GREENFIELD, NH 03047
33aNPI1235115213assigned 12/21/2005
33bProvider typePhysician Assistant
28Total paid$47K
24GClaims571
24DCodes billed6
24AFirst – last monthJun 2020 – Mar 2023
Compared with peers

Next to other Physician Assistant providers in New Hampshire

Rank by total paid#6 of 18
Median peer was paid$3K
This provider vs. median18×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2020410$29K
202112$2K
2022121$13K
202328$4K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
S9083 Global fee urgent care centers 47% 179 178 $22K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 27% 123 102 $13K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 24% 219 190 $11K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.5% 17 16 $687.14
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 0% 14 14 $0.00
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 0% 19 19 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.